SCHEMBL23620909

SCHEMBL23620909

O=P(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(P(=O)(c4ccc(F)cc4)c4ccc(F)cc4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ PPARG P37231 1/20 0.46
▸ NCOA2 Q15596 1/20 0.46
▸ NCOA1 Q15788 1/20 0.46
▸ NCOA3 Q9Y6Q9 1/20 0.46
▸ DPP4 P27487 1/20 0.45
▸ ALDH1A3 P47895 1/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.44
▸ ADCY1 Q08828 3/20 0.43
▸ ADCY8 P40145 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.41
▸ BAD Q92934 1/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ HPGD P15428 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ HTR2A P28223 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20967270 0.98 ABCG2 (0.46) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967380 0.98 ABCG2 (0.46) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967353 0.98 ABCG2 (0.46) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967269 0.98 ABCG2 (0.46) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967352 0.96 ABCG2 (0.44) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967383 0.96 ABCG2 (0.44) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967391 0.96 ABCG2 (0.44) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967358 0.96 ABCG2 (0.44) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL20967468 0.92 TOP1 (0.44) MAPTALDH1A1KDM4EPPARGNCOA2
SCHEMBL21122450 0.89 L3MBTL1 (0.48) MAPTALDH1A1KDM4EL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11063223-B2 Organic electron transport material and organic electroluminescent element using same DYDEN CORPORATION (JP) 2021-07-13 — — US disclosed
US-11063223-B2 Organic electron transport material and organic electroluminescent element using same DYDEN CORPORATION (JP) 2021-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11063223-B2 Organic electron transport material and organic electroluminescent element using same SLCO2A1, SLCO4C1, SLCO2B1 MAPT 3605/4885ALDH1A1 1391/4885KDM4E 2944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback